At Boston Atrial Fibrillation Symposium 2010, Dr. Andrea Russo talked about gender differences in atrial fibrillation treatment, including catheter ablation, as well as women and the risk of stroke from afib.
Watch the video:
Interview with Dr. Andrea Russo at Boston Atrial Fibrillation Symposium 2010
At Boston Atrial Fibrillation Symposium 2010, Dr. Riccardo Cappato talked about the impact of atrial fibrillation on competitive and professional athletes and how catheter ablation for afib has allowed many to return to training and competition. Watch the video, or read the transcript:
Dr. Riccardo Cappato Part 2: Discussion of Athletes and Atrial Fibrillation
At Boston Atrial Fibrillation Symposium 2010, Dr. Riccardo Cappato talked about the results of the Second Worldwide Survey on AF Ablation and how catheter ablation for atrial fibrillation has become safer and more effective. Watch the video, or read the transcript:
Dr. Riccardo Cappato: Discussion of Second Worldwide Survey on AF Ablation
Aspirus Heart & Vascular Institute in Wausau, WI, will present a free seminar on atrial fibrillation treatments on March 2 at which Dr. John Johnkoski and Mellanie True Hills, CEO of StopAfib.org, will speak.
Learn more: Wausau, Wisconsin Atrial Fibrillation Patient Seminar - 03/02/2010
If you’re near Hickory, NC, and want to learn how women can avoid heart disease and stroke, the #1 and #3 killers, please come hear Mellanie True Hills, CEO of StopAfib.org, on February 27.
Mellanie will be keynoting at the Day of Dance for Health, which is sponsored by Frye Regional Medical Center in Hickory, NC, and powered by the Spirit of Women hospital network. You’ll find more info at:
StopAfib.org CEO Mellanie True Hills Keynotes Day of Dance for Health in Hickory, NC
Mellanie True Hills, CEO of StopAfib.org, and St. Joseph Mercy Health System’s (SJMHS) Dr. Manak Sood and Dr. Jihn Han will speak at The Atrial Fibrillation Conference in Ann Arbor, MI on March 4.
Learn more: Ann Arbor, Michigan Atrial Fibrillation Conference
At the recent Boston Atrial Fibrillation Symposium, catheter ablation was presented as possibly a better atrial fibrillation (AF) treatment option for serious and professional athletes than antiarrhythmic drugs (AADs). According to Dr. Riccardo Cappato (Institute Policlinics San Donato, Milan, Italy), antiarrhythmic drug therapy has not been popular with this patient population.”Even when effective, AADs significantly affect an athlete’s physical performance and inhibit eligibility at pre-qualification screenings,” said Dr. Cappato. “Catheter ablation offers an unprecedented opportunity for these athletes to come back to their sport, especially when healthy [pre-participation screening] certificates are required to compete in countries such as mine.”
During the same session, Dr. Stanley Nattel (Montreal Heart Institute, Montreal, Canada) presented a small animal study with rats that suggested that strenuous exercise may have contributed to their development of atrial fibrillation.
To learn more, read: Catheter Ablation May be Better Atrial Fibrillation Treatment than Drugs for Serious and Professional Athletes
February is Heart Month. To kick if off, on Friday, February 5 we celebrate National Wear Red Day® when Americans nationwide wear red to show their support for women’s heart disease awareness.
This event is co-sponsored by the American Heart Association; National Heart, Lung, and Blood Institute; Office on Women’s Health of the U.S. Department of Health and Human Services; and WomenHeart.
To learn more, visit:
Mellanie True Hills, CEO of StopAfib.org, is keynoting the Women’s Power Pulse Luncheon and Expo on February 12, 2010, at the McAllen Convention Center in McAllen, TX. The Women’s Power Pulse Luncheon & Expo is sponsored by Doctors Hospital at Renaissance.
Mellanie provides a message of hope and encouragement, sharing how to take control, decrease stress, and protect against heart disease. She will also talk about atrial fibrillation during this Heart Month event.
For more information on the event, including how to register, see Women’s Power Pulse Luncheon on 02-12-2010
At Boston Atrial Fibrillation Symposium 2010, Prof. John Camm talked about the two newest antiarrhythmic drugs for atrial fibrillation treatment, dronedarone (Multaq®) and vernakalant. These antiarrhythmic (rhythm control) drugs help to put patients back into normal sinus rhythm, or to keep them in it.
See the video: Interview with Professor John Camm at Boston Atrial Fibrillation Symposium 2010
